DK0657164T3 - Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid - Google Patents

Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid

Info

Publication number: DK0657164T3
Authority: DK; Denmark
Prior art keywords: polyalkylene glycol; pharmaceutical compositions; compositions containing; glycol glyceride; staurosporine derivatives
Prior art date: 1993-12-11

Application number

DK94308954T

Other languages

English (en)

Inventor

Roy Lindsay Allen Henry

Graham Paul Matthews

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-11

Filing date

1994-12-02

Publication date

2000-04-17

1994-12-02 Application filed by Novartis Ag filed Critical Novartis Ag

2000-04-17 Application granted granted Critical

2000-04-17 Publication of DK0657164T3 publication Critical patent/DK0657164T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Compositions Of Macromolecular Compounds (AREA)

DK94308954T 1993-12-11 1994-12-02 Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid DK0657164T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939325395A GB9325395D0 (en)	1993-12-11	1993-12-11	Compositions

Publications (1)

Publication Number	Publication Date
DK0657164T3 true DK0657164T3 (da)	2000-04-17

Family

ID=10746475

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94308954T DK0657164T3 (da)	1993-12-11	1994-12-02	Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid

Country Status (17)

Country	Link
US (1)	US5736542A (da)
EP (1)	EP0657164B1 (da)
JP (1)	JPH07196512A (da)
KR (1)	KR100366176B1 (da)
AT (1)	ATE185970T1 (da)
AU (1)	AU692801B2 (da)
CA (1)	CA2137764C (da)
DE (1)	DE69421366T2 (da)
DK (1)	DK0657164T3 (da)
ES (1)	ES2140512T3 (da)
GB (1)	GB9325395D0 (da)
GR (1)	GR3032368T3 (da)
IL (1)	IL111872A (da)
NZ (1)	NZ270109A (da)
PH (1)	PH31454A (da)
PT (1)	PT657164E (da)
ZA (1)	ZA949824B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7795246B2 (en)	1998-08-06	2010-09-14	Cephalon, Inc.	Particle-forming compositions containing fused pyrrolocarbazoles
US6200968B1 (en) *	1998-08-06	2001-03-13	Cephalon, Inc.	Particle-forming compositions containing fused pyrrolocarbazoles
US6242473B1 (en) *	1999-01-08	2001-06-05	Maxim Pharmaceuticals, Inc.	Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
GB9903547D0 (en) *	1999-02-16	1999-04-07	Novartis Ag	Organic compounds
DE19917990A1 (de) *	1999-04-20	2000-11-02	Florian Lang	Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk
EP1201668A4 (en)	1999-07-13	2003-05-21	Kyowa Hakko Kogyo Kk	Staurosporine DERIVATIVES
DE10042137A1 (de) *	2000-08-28	2002-03-14	Florian Lang	sgk2 und sgk3 als diagnostische und therapeutische Targets
BR0208306A (pt) *	2001-03-26	2004-03-09	Novartis Ag	Composições farmacêuticas
EP1613766A1 (de) *	2003-03-03	2006-01-11	Florian Physiologisches Institut I Lang	Sgk1 als diagnostisches und therapeutisches target
US20040246627A1 (en) *	2003-06-06	2004-12-09	Durrum Thomas M.	Disc drive pivot bearing assembly
WO2005014004A1 (en)	2003-08-08	2005-02-17	Novartis Ag	Combinations comprising staurosporines
WO2005016312A1 (en)	2003-08-13	2005-02-24	Nobex Corporation	Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
CA2596405A1 (en) *	2005-02-07	2006-08-10	Topotarget Uk Limited	Assays for agents with selective cytotoxicty to hdac resistant cell lines
US20100168219A1 (en) *	2008-12-31	2010-07-01	Jonathan Steven Alexander	Chronic inflammation and transplantation
US9994585B2 (en)	2007-12-31	2018-06-12	Aphios Corporation	Transplantation therapies
US9034347B2 (en)	2011-12-19	2015-05-19	Arphios Corporation	Drug delivery system and method for the treatment of neuro-degenerative disease
HK1218882A1 (zh)	2012-11-28	2017-03-17	Aphios Corporation	用於治療神經退化疾病和其它疾病的組合治療劑和方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60185719A (ja) *	1984-03-06	1985-09-21	Ajinomoto Co Inc	抗腫瘍剤
JPH0699311B2 (ja) *	1986-11-06	1994-12-07	旭化成工業株式会社	抗血管レン縮剤および血管弛緩剤
US5093330A (en) *	1987-06-15	1992-03-03	Ciba-Geigy Corporation	Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) *	1987-06-15	1988-11-30	Ciba Geigy Ag	Derivatives substituted at methyl-amino nitrogen
JPH01143877A (ja) *	1987-11-30	1989-06-06	Asahi Chem Ind Co Ltd	スタウロスポリン誘導体
WO1989007105A1 (en) *	1988-02-04	1989-08-10	Kyowa Hakko Kogyo Co., Ltd.	Staurosporin derivatives
JPH0725786A (ja) *	1990-05-16	1995-01-27	Univ Rockefeller	アルツハイマー病を伴うアミロイドーシスの治療
JPH06501024A (ja) *	1991-03-29	1994-01-27	アメリカ合衆国	皮膚腫瘍形成を予防し、存在する腫瘍の後退の原因になるための医薬組成物と方法
JPH0597708A (ja) *	1991-10-02	1993-04-20	Lion Corp	歯周病治療剤
AU2866992A (en) *	1991-10-10	1993-05-03	Schering Corporation	4'-(n-substituted-n-oxide)staurosporine derivatives
JPH05247055A (ja) *	1992-03-03	1993-09-24	Meiji Seika Kaisha Ltd	スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤

1993
- 1993-12-11 GB GB939325395A patent/GB9325395D0/en active Pending
1994
- 1994-11-18 PH PH49409A patent/PH31454A/en unknown
- 1994-11-22 US US08/343,404 patent/US5736542A/en not_active Expired - Fee Related
- 1994-12-02 ES ES94308954T patent/ES2140512T3/es not_active Expired - Lifetime
- 1994-12-02 AT AT94308954T patent/ATE185970T1/de active
- 1994-12-02 DE DE69421366T patent/DE69421366T2/de not_active Expired - Lifetime
- 1994-12-02 PT PT94308954T patent/PT657164E/pt unknown
- 1994-12-02 EP EP94308954A patent/EP0657164B1/en not_active Expired - Lifetime
- 1994-12-02 DK DK94308954T patent/DK0657164T3/da active
- 1994-12-05 IL IL111872A patent/IL111872A/en not_active IP Right Cessation
- 1994-12-08 AU AU80308/94A patent/AU692801B2/en not_active Ceased
- 1994-12-09 NZ NZ270109A patent/NZ270109A/en not_active IP Right Cessation
- 1994-12-09 CA CA002137764A patent/CA2137764C/en not_active Expired - Fee Related
- 1994-12-09 KR KR1019940033397A patent/KR100366176B1/ko not_active Expired - Fee Related
- 1994-12-09 ZA ZA949824A patent/ZA949824B/xx unknown
- 1994-12-12 JP JP6307534A patent/JPH07196512A/ja active Pending
2000
- 2000-01-14 GR GR20000400066T patent/GR3032368T3/el unknown

Also Published As

Publication number	Publication date
KR960021018A (ko)	1996-07-18
KR100366176B1 (ko)	2003-03-03
DE69421366T2 (de)	2000-03-23
US5736542A (en)	1998-04-07
GR3032368T3 (en)	2000-04-27
AU8030894A (en)	1995-06-22
CA2137764C (en)	2006-02-07
DE69421366D1 (de)	1999-12-02
EP0657164B1 (en)	1999-10-27
AU692801B2 (en)	1998-06-18
ES2140512T3 (es)	2000-03-01
ZA949824B (en)	1995-07-13
PH31454A (en)	1998-11-03
IL111872A (en)	1998-02-08
NZ270109A (en)	1996-11-26
EP0657164A1 (en)	1995-06-14
PT657164E (pt)	2000-04-28
IL111872A0 (en)	1995-06-29
JPH07196512A (ja)	1995-08-01
CA2137764A1 (en)	1995-06-12
GB9325395D0 (en)	1994-02-16
ATE185970T1 (de)	1999-11-15

Publication	Publication Date	Title
DK0657164T3 (da)	2000-04-17	Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid
ES2186715T3 (es)	2003-05-16	Uso de un tensioactivo lipofilico en una composicion farmaceutica.
ATE153854T1 (de)	1997-06-15	Stabile pharmazeutische zubereitung mit fumagillolderivaten
DE69232818D1 (de)	2002-11-21	Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
FI872481A0 (fi)	1987-06-03	Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
LV11884A (lv)	1997-12-20	Ciklosporina oralas arstnieciskas formas ar augstu biopieejamibu
NO940277L (no)	1994-07-28	Triglycerider og blandinger av slike
JPS5777626A (en)	1982-05-15	Palatable composition containing oil or oily substance
DE60205633D1 (de)	2005-09-22	Orale pharmazeutische zusammensetzung mit einem wirkstoff, der bei seiner ersten darmpassage starken wirkungen ausgesetzt werden kann
KR950010875A (ko)	1995-05-15	피부외용제
DE3171928D1 (en)	1985-09-26	Pharmaceutical formulation and its preparation
IE893718L (en)	1990-05-22	Pharmaceutical Compositions
IL86395A (en)	1992-11-15	Pharmaceutical compositions with improved bioavailability containing flunarizine and polyethoxylated castor oil
EA200200415A1 (ru)	2002-10-31	Композиция фармацевтического носителя
JPS5772908A (en)	1982-05-07	Removing agent for make-up cosmetic
ES2141049B1 (es)	2000-10-16	Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
GR900100076A (en)	1991-06-28	Preparation method of novel pharmaceutical forms of cyclosporine